Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

计划入组 20 人 · 首次发布于 2002 年 11 月 1 日

Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor

计划入组 20 人 · 首次发布于 2024 年 1 月 23 日

Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.

计划入组 25 人 · 首次发布于 2010 年 7 月 20 日

IL-1 receptor type 2 (Immunex)

Muplestim

LAMELLASOME CF-NA

Immunex Corporation

United States

Immunex Rhode Island Corporation

United States

IMMUNEXPRESS PTY LTD

Australia

Antitrust Battle Over Enbrel Monopoly Escalates as Amici Clash in Fourth Circuit Appeals

HRSA Approves Eight Drug Companies for 340B Rebate Model Pilot Program Starting January 2025

Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer to Lead CAR-T Therapy Launch